22-Jan-2020 - osteolabs GmbH

Osteolabs GmbH receives major contract

osteolabs GmbH announced the successful closing of its first commercial agreements for Germany and Turkey. For Germany, the company has signed up with Eurofins LifeCodexx GmbH as exclusive partner in the field of gynecology for the commercialization of its novel diagnostic test for early detection of osteoporosis. Eurofins LifeCodexx became a market leader in this gynecology segment over the last couple of years as first provider of PraenaTest®, a non-invasive prenatal testing method (NIPT) for detection of fetal trisomies from maternal blood. For Turkey, a similiar commercial agreement has been signed with BioGen Medical, a leading distributor for laboratory developed tests.

Moreover, the osteolabs test will be used in a comprehensive contract research collaboration with the Health Department of an European Army over the course of 3 years. During that time, over 1,000 tests will be performed to determine the correlation of calcium depletion with intense physical activities and bone fractures in female military staff. The application of the osteoporosis test should allow to further validate the potential of the test for early detection of calcium depletion from the skeleton which could be further used for therapeutic monitoring of osteoporosis medications.

On the occasion of the opening of its new facilities in presence of the Minister for Economic and Technological Affairs of Schleswig-Holstein, Dr. Stefan Kloth, Managing Director osteolabs GmbH said: „We are extremely pleased with the company developments since our 1st financing round closing in summer 2019. With the first two commercial agreements we will be in a good position in Germany and Turkey to accelerate uptake of our novel testing method.“

osteolab´s Chief Scientist Prof. Dr. Anton Eisenhauer commented: „The joint research collaboration together is a strong recognition of the potential of our novel testing method for osteoporosis. With this collaboration we intend to examine whether female military staff experience health issues from calcium depletion as an imbalance in calcium supply may lead to bone fractures even at younger age.“

Dr. Bernd Buchholz, Minister for Economic and Technology Affairs, said: „osteolabs is a perfect example of successful and creative technology transfer in Schleswig-Holstein.” At the interface between marine research at GEOMAR and the outstanding life sciences expertise located in northern Germany, marketable ideas ready for application in medical diagnostics have been developed which are now bearing fruit at the international level as well.

The Minister pointed out that osteolabs, originally a project on the early detection of osteoporosis, was a spin-off from the GEOMAR Helmholtz-Center of Marine Sciences. Common properties found in both corals and osteoporosis had been the point of departure. In collaboration with physicians from the University Medical Center Schleswig-Holstein (UK.SH), oceanographers from GEOMAR had transferred methods used for calcium assays in marine research on corals to the diagnostics of osteoporosis. “And thus, a rapid diagnostic test for the early detection of osteoporosis that doesn’t use x-rays was developed,” Minister Buchholz explained.

Facts, background information, dossiers
More about osteolabs
  • News

    Osteolabs GmbH successfully closes seed financing round

    Osteolabs GmbH announced the successful closing of its seed financing round with contributions by Seed und Start-Up Fonds II of MBG (Mittelständische Beteiligungsgesellschaft) Kiel (Germany), Laboratory MVZ Dr. Krause und Kollegen (Kiel, Germany) and two life sciences related business angel ... more

  • Companies

    osteolabs GmbH

    In order to detect osteoporosis early, osteolabs uses trace elements in the human body as biomarkers. A little urine is enough to tell whether you are suffering from bone loss or not. With this worldwide unique test you can detect osteoporosis earlier than on an x-ray. Osteolabs brings th ... more